Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Study of B72.3 combining sites by molecular modeling and site-directed mutagenesis.

Xiang J, Srivamadan M, Rajala R, Jia Z.

Protein Eng. 2000 May;13(5):339-44.

PMID:
10835107
3.
4.

Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.

Wu H, Nie Y, Huse WD, Watkins JD.

J Mol Biol. 1999 Nov 19;294(1):151-62.

PMID:
10556035
6.

Identification of residues in the monoclonal antitumor antibody L6 important for binding to its tumor antigen.

Stenzel-Johnson PR, Yelton D, Bajorath J.

Biochemistry. 1994 Dec 6;33(48):14400-6.

PMID:
7526900
7.

Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten.

Strong RK, Campbell R, Rose DR, Petsko GA, Sharon J, Margolies MN.

Biochemistry. 1991 Apr 16;30(15):3739-48.

PMID:
2015229
8.

Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.

Schildbach JF, Shaw SY, Bruccoleri RE, Haber E, Herzenberg LA, Jager GC, Jeffrey PD, Panka DJ, Parks DR, Near RI, et al.

Protein Sci. 1994 May;3(5):737-49.

9.

Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.

Vajdos FF, Adams CW, Breece TN, Presta LG, de Vos AM, Sidhu SS.

J Mol Biol. 2002 Jul 5;320(2):415-28.

PMID:
12079396
10.
11.
12.

The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.

Giles I, Lambrianides N, Latchman D, Chen P, Chukwuocha R, Isenberg D, Rahman A.

Arthritis Res Ther. 2005;7(1):R47-56. Epub 2004 Nov 16.

13.

Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.

Paula S, Monson N, Ball WJ Jr.

Proteins. 2005 Aug 15;60(3):382-91.

PMID:
15971203
14.

Molecular modelling and site-directed mutagenesis on a bovine anti-testosterone monoclonal antibody.

Jackson T, Morris BA, Martin AC, Lewis DF, Sanders PG.

Protein Eng. 1992 Jun;5(4):343-50.

PMID:
1409555
15.

Characterization of an anti-digoxin antibody binding site by site-directed in vitro mutagenesis.

Near RI, Mudgett-Hunter M, Novotny J, Bruccoleri R, Ng SC.

Mol Immunol. 1993 Mar;30(4):369-77.

PMID:
8455637
16.

Three-dimensional model of the BR96 monoclonal antibody variable fragment.

Bajorath J.

Bioconjug Chem. 1994 May-Jun;5(3):213-9.

PMID:
7522581
17.

Mapping the paratope of anti-CD4 recombinant Fab 13B8.2 by combining parallel peptide synthesis and site-directed mutagenesis.

Bès C, Briant-Longuet L, Cerutti M, Heitz F, Troadec S, Pugnière M, Roquet F, Molina F, Casset F, Bresson D, Péraldi-Roux S, Devauchelle G, Devaux C, Granier C, Chardes T.

J Biol Chem. 2003 Apr 18;278(16):14265-73. Epub 2003 Feb 3.

18.

Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.

Liu Z, Song D, Kramer A, Martin AC, Dandekar T, Schneider-Mergener J, Bautz EK, Dübel S.

J Mol Recognit. 1999 Mar-Apr;12(2):103-11.

PMID:
10398401
19.
20.

Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1.

Holm P, Jafari R, Sundström BE.

Mol Immunol. 2007 Feb;44(6):1075-84. Epub 2006 Sep 20.

PMID:
16989900

Supplemental Content

Support Center